• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对糖尿病合并抑郁症状患者的社区综合护理模式的成本效益

Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms.

作者信息

Wang Yanshang, Guo Dan, Xia Yiqi, Hu Mingzheng, Wang Ming, Shi Zhenyu, Guan Xiaolong, Zhu Dawei, He Ping

机构信息

School of Public Health, Peking University, Beijing, China.

China Center for Health Development Studies, Peking University, Beijing, China.

出版信息

Nat Commun. 2025 Mar 27;16(1):2986. doi: 10.1038/s41467-025-58120-x.

DOI:10.1038/s41467-025-58120-x
PMID:40140402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11947312/
Abstract

The coexistence of type 2 diabetes (T2DM) and depression is a prominent example of multimorbidity. In previous work, we reported the results of a completed cluster-randomized controlled trial that was conducted in eight community health centers in China. We enrolled adults (≥18 years) with type 2 diabetes and depressive symptoms. In the intervention group, a comprehensive care plan was developed based on the Integrated Care Model for Patients with Diabetes and Depression (CIC-PDD). In this study, we explore the cost-effectiveness of the CIC-PDD by conducting a one-year within-trial economic evaluation from the health system, multipayer and societal perspectives. Health outcomes are quality-adjusted life years (QALYs) and depression-free days (DFDs), and we calculate incremental cost-effectiveness ratios (ICERs) and cost-effectiveness probability. Among 630 participants (275 intervention, 355 usual care), the cost per QALY gained is $7,922.82, $7,823.85, and $7,409.46, with cost-effectiveness probabilities of 66.41%- 94.45%. The cost per DFD is $2.63-$2.82, requiring a willingness-to-pay of $9.00-$10.50 for >95% probability of cost-effectiveness. We find that the CIC-PDD model demonstrates cost-effectiveness within primary health care settings, but further studies are needed to assess its long-term sustainability and scalability. Trial registration: 35 ChiCTR2200065608.

摘要

2型糖尿病(T2DM)与抑郁症并存是共病的一个突出例子。在之前的工作中,我们报告了在中国八个社区卫生中心进行的一项已完成的整群随机对照试验的结果。我们纳入了患有2型糖尿病和抑郁症状的成年人(≥18岁)。在干预组中,基于糖尿病与抑郁症患者综合照护模型(CIC-PDD)制定了综合照护计划。在本研究中,我们从卫生系统、多支付方和社会角度进行了为期一年的试验内经济评估,以探讨CIC-PDD的成本效益。健康结局为质量调整生命年(QALYs)和无抑郁天数(DFDs),我们计算了增量成本效益比(ICERs)和成本效益概率。在630名参与者中(275名干预组,355名常规照护组),每获得一个QALY的成本分别为7922.82美元、7823.85美元和7409.46美元,成本效益概率为66.41%-94.45%。每增加一个DFD的成本为2.63-2.82美元,成本效益概率>95%时需要的支付意愿为9.00-10.50美元。我们发现CIC-PDD模型在初级卫生保健环境中显示出成本效益,但需要进一步研究来评估其长期可持续性和可扩展性。试验注册:35 ChiCTR2200065608。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8c/11947312/625a9dd1c89b/41467_2025_58120_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8c/11947312/e261d1612e1b/41467_2025_58120_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8c/11947312/625a9dd1c89b/41467_2025_58120_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8c/11947312/e261d1612e1b/41467_2025_58120_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8c/11947312/625a9dd1c89b/41467_2025_58120_Fig2_HTML.jpg

相似文献

1
Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms.针对糖尿病合并抑郁症状患者的社区综合护理模式的成本效益
Nat Commun. 2025 Mar 27;16(1):2986. doi: 10.1038/s41467-025-58120-x.
2
Cost-Effectiveness of a Collaborative Care Model Among Patients With Type 2 Diabetes and Depression in India.印度 2 型糖尿病合并抑郁症患者的协同护理模式的成本效益分析。
Diabetes Care. 2023 Jan 1;46(1):11-19. doi: 10.2337/dc21-2533.
3
Economic Evaluation of a Web Application Implemented in Primary Care for the Treatment of Depression in Patients With Type 2 Diabetes Mellitus: Multicenter Randomized Controlled Trial.在初级保健中实施的用于治疗 2 型糖尿病伴发抑郁症的网络应用的经济学评价:多中心随机对照试验。
JMIR Mhealth Uhealth. 2024 May 16;12:e55483. doi: 10.2196/55483.
4
Long-term cost-effectiveness of health behaviour intervention to manage type 2 diabetes in Nepal.尼泊尔2型糖尿病健康行为干预的长期成本效益
BMC Med. 2025 Mar 11;23(1):153. doi: 10.1186/s12916-025-03981-8.
5
Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.协作式照护(与常规照护相比)对伴有抑郁症及共病糖尿病或心血管疾病患者的长期成本效益:一项基于COINCIDE随机对照试验的马尔可夫模型研究
BMJ Open. 2016 Oct 7;6(10):e012514. doi: 10.1136/bmjopen-2016-012514.
6
Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa.美国萨摩亚以群组为基础、文化适配、社区卫生工作者家访式糖尿病干预与标准护理的成本效益分析。
Hum Resour Health. 2019 Mar 5;17(1):17. doi: 10.1186/s12960-019-0356-6.
7
Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care.初级保健中糖尿病与抑郁症协作护理的成本效益评估
Am J Prev Med. 2016 Jul;51(1):e13-20. doi: 10.1016/j.amepre.2016.01.010.
8
Community-based integrated care for patients with diabetes and depression (CIC-PDD): study protocol for a cluster randomized controlled trial.基于社区的糖尿病合并抑郁症患者综合管理(CIC-PDD):一项群组随机对照试验研究方案。
Trials. 2023 Aug 22;24(1):550. doi: 10.1186/s13063-023-07561-0.
9
Effect of Community-Based Integrated Care for Patients With Diabetes and Depression (CIC-PDD) in China: A Pragmatic Cluster-Randomized Trial.中国社区糖尿病与抑郁症患者综合照护(CIC-PDD)的效果:一项实用性整群随机试验
Diabetes Care. 2025 Feb 1;48(2):226-234. doi: 10.2337/dc24-1593.
10
Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.与常规护理相比,为2型糖尿病患者提供便捷的自我管理网站的成本效益(HeLP-糖尿病研究):随机对照试验
J Med Internet Res. 2018 Jun 8;20(6):e201. doi: 10.2196/jmir.9256.

本文引用的文献

1
Effect of Community-Based Integrated Care for Patients With Diabetes and Depression (CIC-PDD) in China: A Pragmatic Cluster-Randomized Trial.中国社区糖尿病与抑郁症患者综合照护(CIC-PDD)的效果:一项实用性整群随机试验
Diabetes Care. 2025 Feb 1;48(2):226-234. doi: 10.2337/dc24-1593.
2
Community-based integrated care for patients with diabetes and depression (CIC-PDD): study protocol for a cluster randomized controlled trial.基于社区的糖尿病合并抑郁症患者综合管理(CIC-PDD):一项群组随机对照试验研究方案。
Trials. 2023 Aug 22;24(1):550. doi: 10.1186/s13063-023-07561-0.
3
Projected rapid growth in diabetes disease burden and economic burden in China: a spatio-temporal study from 2020 to 2030.
中国糖尿病疾病负担和经济负担的预计快速增长:一项2020年至2030年的时空研究
Lancet Reg Health West Pac. 2023 Feb 3;33:100700. doi: 10.1016/j.lanwpc.2023.100700. eCollection 2023 Apr.
4
Cost-Effectiveness of a Collaborative Care Model Among Patients With Type 2 Diabetes and Depression in India.印度 2 型糖尿病合并抑郁症患者的协同护理模式的成本效益分析。
Diabetes Care. 2023 Jan 1;46(1):11-19. doi: 10.2337/dc21-2533.
5
Effectiveness of Collaborative Care for Depression and HbA1c in Patients with Depression and Diabetes: A Systematic Review and Meta-Analysis.抑郁症合并糖尿病患者中抑郁症与糖化血红蛋白的协作护理效果:一项系统评价与荟萃分析
Int J Integr Care. 2022 Aug 30;22(3):12. doi: 10.5334/ijic.6443. eCollection 2022 Jul-Sep.
6
Costs of multimorbidity: a systematic review and meta-analyses.共病的成本:系统评价和荟萃分析。
BMC Med. 2022 Jul 19;20(1):234. doi: 10.1186/s12916-022-02427-9.
7
Cost-effectiveness of the Adaptive Implementation of Effective Programs Trial (ADEPT): approaches to adopting implementation strategies.有效项目适应性实施试验(ADEPT)的成本效益:采用实施策略的方法。
Implement Sci. 2020 Dec 14;15(1):109. doi: 10.1186/s13012-020-01069-w.
8
The impact of mental and physical multimorbidity on healthcare utilization and health spending in China: A nationwide longitudinal population-based study.精神和躯体共病对中国医疗保健利用和卫生支出的影响:一项全国性纵向基于人口的研究。
Int J Geriatr Psychiatry. 2021 Apr;36(4):500-510. doi: 10.1002/gps.5445. Epub 2020 Oct 16.
9
Cost and effects of integrated care: a systematic literature review and meta-analysis.整合照护的成本与效果:系统文献回顾与荟萃分析。
Eur J Health Econ. 2020 Nov;21(8):1211-1221. doi: 10.1007/s10198-020-01217-5. Epub 2020 Jul 6.
10
Healthcare use in patients with multimorbidity.多发病患者的医疗保健利用情况。
Eur J Public Health. 2020 Feb 1;30(1):16-22. doi: 10.1093/eurpub/ckz118.